GLP-1 Analogue Effects on Food Cues, Stress, Motivation for Highly Palatable Foods, and Weight
Status:
Recruiting
Trial end date:
2025-06-30
Target enrollment:
Participant gender:
Summary
To examine response to a glucagon-like peptide-1 analogue vs. placebo in patients with
obesity and assess impact on craving, hunger, stress, and weight outcomes.
Phase:
Phase 1
Details
Lead Sponsor:
Yale University
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)